引用本文: | 王树森, 孙业桓. PALOMA-3研究分析: 氟维司群联合Palbociclib显著提高内分泌治疗进展的晚期乳腺癌的无进展生存期[J]. 循证医学, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009 |
Citation: | Reviewer: WANG Shu-sen, Literature Co-worker: ZHANG Liu-lu. PALOMA-3 Trial: Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 152-154. DOI: 10.12019/j.issn.1671-5144.2016.03.009 |